These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 7448733)

  • 21. [Hormone receptors and breast cancer prognosis].
    Saez S; Pichon MF
    Pathol Biol (Paris); 1983 Dec; 31(10):801-8. PubMed ID: 6366701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen receptor negative and progesterone receptor positive primary breast cancer: pathological characteristics and clinical outcome. Institut Curie Breast Cancer Study Group.
    Bernoux A; de Cremoux P; Lainé-Bidron C; Martin EC; Asselain B; Magdelénat H
    Breast Cancer Res Treat; 1998 Jun; 49(3):219-25. PubMed ID: 9776505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases.
    Bardou VJ; Arpino G; Elledge RM; Osborne CK; Clark GM
    J Clin Oncol; 2003 May; 21(10):1973-9. PubMed ID: 12743151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen.
    Bonomi P; Gale M; Von Roenn J; Anderson K; Johnson P; Wolter J; Economou S
    Semin Oncol; 1988 Apr; 15(2 Suppl 1):26-33. PubMed ID: 3368797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of estrogen and progesterone receptors in primary breast cancer.
    Saez S; Cheix F; Asselain B
    Breast Cancer Res Treat; 1983; 3(4):345-53. PubMed ID: 6667349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-proliferative activity, progesterone receptor status, estrogen receptor level, and clinical outcome of estrogen receptor-positive advanced breast cancer.
    Paradiso A; Tommasi S; Mangia A; Lorusso V; Simone G; De Lena M
    Cancer Res; 1990 May; 50(10):2958-62. PubMed ID: 2334898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors associated with prognosis in human breast cancer. IV. Progesterone receptors and clinical factors.
    Macías A; Pascual MR; Pérez R; Lage A
    Neoplasma; 1983; 30(5):593-601. PubMed ID: 6656963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen and progesterone receptors as prognostic factors in breast cancer.
    Brdar B; Graf D; Padovan R; Nola P; Rudan N; Petrinec Z; Sarcević B; Belicza M
    Tumori; 1988 Feb; 74(1):45-52. PubMed ID: 3354064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The variation and clinical significance of hormone receptors and Her-2 status from primary to metastatic lesions in breast cancer patients.
    Zhu YY; Si W; Ji TF; Guo XQ; Hu Y; Yang JL
    Tumour Biol; 2016 Jun; 37(6):7675-84. PubMed ID: 26687919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen and progesterone receptors status in the prediction of response of breast cancer to endocrine therapy (preliminary report).
    Nardelli GB; Lamaina V; Siliotti F
    Eur J Gynaecol Oncol; 1986; 7(3):151-8. PubMed ID: 3536517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.
    Foekens JA; Portengen H; van Putten WL; Peters HA; Krijnen HL; Alexieva-Figusch J; Klijn JG
    Cancer Res; 1989 Nov; 49(21):5823-8. PubMed ID: 2676151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progesterone receptor status and clinical outcome in breast cancer patients with estrogen receptor-positive locoregional recurrence.
    Bogina G; Lunardi G; Coati F; Zamboni G; Gori S; Bortesi L; Marconi M; Cassandrini PA; Turazza M; Cortesi L; DeMatteis E; Ficarra G; Ibrahim T; Serra P; Medri L; Giraudi S; Lambertini M; Carli F; Foglietta J; Sidoni A; Nunzi M; Ficorella C; Diadema MR; Del Mastro L
    Tumori; 2015; 101(4):398-403. PubMed ID: 26045108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.
    Encarnación CA; Ciocca DR; McGuire WL; Clark GM; Fuqua SA; Osborne CK
    Breast Cancer Res Treat; 1993; 26(3):237-46. PubMed ID: 8251648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer.
    Johnston SR; Saccani-Jotti G; Smith IE; Salter J; Newby J; Coppen M; Ebbs SR; Dowsett M
    Cancer Res; 1995 Aug; 55(15):3331-8. PubMed ID: 7614468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human breast cancer: survival from first metastasis. Breast Cancer Study Group.
    Koenders PG; Beex LV; Kloppenborg PW; Smals AG; Benraad TJ
    Breast Cancer Res Treat; 1992; 21(3):173-80. PubMed ID: 1515652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution of estrogen and progesterone receptors in primary tumor and lymph nodes in individual patients with breast cancer.
    Coradini D; Cappelletti V; Miodini P; Ronchi E; Scavone G; Di Fronzo G
    Tumori; 1984 Apr; 70(2):165-8. PubMed ID: 6730015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical determination of estrogen and progesterone receptors in breast cancer: relationship with clinicopathologic factors in 302 patients in Ivory Coast.
    Effi AB; Aman NA; Koui BS; Koffi KD; Traoré ZC; Kouyate M
    BMC Cancer; 2017 Feb; 17(1):115. PubMed ID: 28173783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of relapse and survival in breast cancer patients by pS2 protein status.
    Foekens JA; Rio MC; Seguin P; van Putten WL; Fauque J; Nap M; Klijn JG; Chambon P
    Cancer Res; 1990 Jul; 50(13):3832-7. PubMed ID: 2354435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steroid receptors in breast cancer.
    Desombre ER
    Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative oestrogen and progesterone receptor values in primary breast cancer and predictability of response to endocrine therapy.
    Fernandez MD; Alaghband-Zadeh J; Burn JI
    Clin Oncol; 1983 Sep; 9(3):245-50. PubMed ID: 6616999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.